Former President Joe Biden is undergoing a new phase of treatment for an aggressive form of cancer that was diagnosed in May, a spokesperson said Saturday. "As part of a treatment plan for prostate ...

Victor Sung, M.D., director of the Division of Movement Disorders in the University of Alabama at Birmingham Department of Neurology and director of the UAB Huntington’s Disease Clinic, reacted to the ...

A new treatment that proves to slow the progression of Huntington’s disease (HD) marks a breakthrough for a condition that has long been considered untreatable. Huntington’s is a rare, inherited ...

A gene therapy injected into patients’ brains slowed progression of the disease by 75 percent, preliminary findings reported. By Dana G. Smith Preliminary results from a small clinical trial to treat ...

With informed consent, you generally have the right to seek a second opinion or refuse treatment unless refusing poses a danger to the community or a court of law declares you “mentally incompetent.” ...

Turning 90 is prompting me to finally become a responsible adult. A functioning member of society — beginning with obeying a doctor’s orders! That’s a low bar — but I’ve got to start somewhere. For ...

ROANOKE, Va. (WDBJ) - A growing number of people in Central Virginia are being diagnosed with Alpha-Gal Syndrome. It’s an allergy caused by tick bites that makes eating—or even being near—meat or ...

Shawn Connolly, a former skateboarding professional, follows the directions of Nicholas B. Galifianakis, MD, while testing a deep brain stimulation treatment for Parkinson’s disease. Photo by Maurice ...

Hidradenitis suppurativa is managed with biologics like adalimumab and secukinumab, approved for moderate-to-severe cases. Adalimumab, a TNF-α inhibitor, was FDA-approved in 2015, while secukinumab, ...

MISSION VIEJO, Calif. (KABC) -- It's being called a potential game-changer in fighting certain types of cancer and it uses highly-focused soundwaves. For destroying tumors, histotripsy offers many ...

Mona Bafadhel receives funding from the National Institute of Health Research, Asthma+Lung UK, and Horizon Europe. For this study, Mona Bafadhel received funding from AstraZeneca to complete the study ...